Software licensing for analysis research efforts.
Ended Purchase Order Awarded Last action
- Contract number
- W81XWH22P0161
- Awardee
-
Simulations Plus Inc. UEI MZN6WDBMXN24
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $144,335
Award facts
- Opportunity
-
- GastroPlus software licenses Special Notice · W81XWH22Q0086 · Posted Aug 21, 2022
- Contract value 100% obligated
- $144,335.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 511210 Software Publishers
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Lancaster, CA 93534, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $49,544 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $48,101 | |
| Original award | $46,690 |
About this award
The Defense Health Agency awarded a $144,335 firm fixed-price purchase order to Simulations Plus Inc. on September 15, 2022, for software licensing to support analysis research efforts. The contract calls for the purchase of GastroPlus licenses, a simulation software package that models drug absorption, pharmacokinetics, and pharmacodynamics across multiple administration routes including intravenous, oral, ocular, inhalation, dermal, subcutaneous, and intramuscular pathways in animal subjects. The work is performed in Lancaster, California, with an ultimate completion date of September 14, 2025. No set-aside designation was applied to this procurement, which was solicited as a special notice posted on August 21, 2022.
Simulations Plus Inc., a specialized pharmaceutical modeling and simulation software developer, is well-established in providing computational tools to federal agencies for drug discovery, development, and regulatory assessment. The company's GastroPlus software and related products support physiologically-based pharmacokinetic modeling and virtual bioequivalence studies, applications critical to the Defense Health Agency's research mission. The Defense Health Agency's procurement of these licenses aligns with the department's need for advanced analytical capabilities to evaluate pharmaceutical products for military medical applications and support evidence-based regulatory decision-making in drug development.
Quick answers
Who was awarded contract W81XWH22P0161?
W81XWH22P0161 was awarded to Simulations Plus Inc. by Defense Health Agency (Department of Defense) on September 15, 2022.
How much is contract W81XWH22P0161 worth?
The government has obligated $144,335 on W81XWH22P0161.
Was contract W81XWH22P0161 competed?
The extent of competition for W81XWH22P0161 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award